Latest news with #cardiaccare
Arab News
4 days ago
- Health
- Arab News
East Arafat Hospital's mobile unit performs 14 emergency cardiac procedures during Hajj
MAKKAH: A mobile unit of East Arafat Hospital's Cardiology Department has successfully performed 14 emergency cardiac catheterization procedures since it began operations on the first day of Hajj, the Makkah Health Cluster has announced. The procedures are being conducted under the direct field supervision of King Abdullah Medical City based in Makkah city, the health cluster said in a statement carried by the Saudi Press Agency, or SPA. Composed of a specialized cardiology team, supported by qualified Saudi professionals in anesthesia, nursing, and urgent cardiac care, the mobile cardiac catheterization unit is deployed at the holy sites to provide immediate on-site intervention. Officials said the initiative eliminates the need to transfer patients to specialized centers, 'thereby enhancing patient safety and ensuring continuous medical care.' Meanwhile, the Air Medical Evacuation team at the Ministry of Defense rescued an Indonesian pilgrim who suffered a cardiac arrest on June 5 in Makkah. The patient was airlifted from Al Noor Hospital in Makkah to King Abdulaziz Specialist Hospital in Taif city. Air evacuation units stationed near the holy sites ensure rapid emergency response, improving rescue times and increasing survival rates. Health officials had earlier announced the successful test of a new service transporting medicine with drones during Hajj, which started June 4 and will run until June 9. As reported earlier by Arab News, Health Minister Fahad AlJalajel the drone delivery trials over the past two years tested for safe takeoff and landing, as well as high temperatures. The drones are equipped with cooling systems, he said. The drone initiative is a part of the comprehensive healthcare transformation taking place in the Kingdom, under the Saudi Vision 2030 program.
Free Malaysia Today
5 days ago
- Business
- Free Malaysia Today
IJN successfully implants dual-chamber leadless pacemaker, a first in Southeast Asia
Senior consultant cardiologist Dr Azlan Hussin (left), IJN CEO Dr Ezani Taib (right) and chief clinical officer Dr Shaiful Azmi Yahya holding the dual-chamber leadless pacemaker device at the press conference today. (Bernama pic) PETALING JAYA : The National Heart Institute (IJN) today announced it has successfully implanted the world's first dual-chamber leadless pacemaker system, the Abbott AVEIR™ DR, on several of its patients. Senior consultant cardiologist and interventional electrophysiology & implantable devices clinical director Dr Azlan Hussin said it was also a historic achievement as IJN is the first hospital in Southeast Asia to carry out the procedure. At a press conference today, he said this major achievement reflects IJN's commitment to setting new standards in cardiac care. 'This groundbreaking dual-chamber leadless pacemaker will revolutionise care for our current patients and create a significant opportunity to expand the number of people we can serve, including children. 'By eliminating traditional wires (leads) and surgical pockets, this leadless system significantly reduces the risk of complications such as infections, lead dislodgement, or vessel occlusion,' Azlan said. He added that 18 patients have received the new device, with the first procedure carried out on May 27. According to Azlan, this milestone also builds on IJN's decade-long experience with leadless pacemaker technology, during which nearly 900 patients have undergone procedures involving wireless pacemakers. He said the long-term complication rate is typically 1-2%, comparable to and, in some cases, lower than that of conventional pacemakers. Azlan said the AVEIR™ DR system offers a range of potential benefits, including a shorter procedure time of about 20 minutes to one hour, depending on the patient's heart condition. 'The system also provides real-time pacing analysis, enabling physicians to confirm accurate device placement during the procedure before the final implantation into the heart chamber,' he said. IJN CEO Dr Ezani Taib told reporters the new procedure comes with a slight increase in cost, but that it was normal with any new technology. 'As with any new technology, the initial cost is slightly higher. However, in general, IJN's charges are significantly lower than those at most private hospitals,' he said. When asked if other hospitals in the country could also perform the procedure, Ezani explained that IJN had both the right expertise and infrastructure to offer the service. 'People need to understand this is not just about business. It's about having the clinical expertise, advanced technology, and the right facilities. 'At IJN, innovation isn't just about introducing new technology, it's about creating real, meaningful impact. The AVEIR™ DR implantation marks a leap forward in cardiac care and reinforces our role as a regional leader,' he said. Ezani also emphasised the importance of awareness and early intervention in addressing cardiovascular disease, which remains a significant health challenge in Malaysia. The AVEIR™ DR system, designed for patients with slow or irregular heart rhythms, marks a major breakthrough in cardiac pacing. Unlike traditional pacemakers, the AVEIR™ DR system consists of two miniaturised devices, each one-tenth the size of conventional models, implanted directly into the heart's right atrium and ventricle. The AVEIR™ DR system consists of two miniaturised devices that are implanted directly into the heart's right atrium and ventricle. (Bernama pic) As the world's first dual-chamber leadless pacemaker, it provides synchronised, beat-to-beat pacing without the risks associated with leads. The system features a minimally invasive design, long-term retrievability, and future-ready adaptability. In 2018, IJN made history as the first hospital outside the US to implant the world's smallest pacemaker, the Micra AV.
Malay Mail
5 days ago
- Business
- Malay Mail
IJN makes history as first in SE Asia to implant dual-chamber wireless pacemaker
KUALA LUMPUR, June 5 — The National Heart Institute (IJN) has made medical history by becoming the first centre in South-east Asia to successfully implant the world's first dual-chamber leadless pacemaker system, the Abbott AVEIR™ DR. Senior consultant cardiologist and Interventional Electrophysiology & Implantable Devices clinical director Datuk Dr Azlan Hussin said the achievement reflects IJN's commitment to setting new standards in cardiac care both in Malaysia and the region. 'This groundbreaking dual-chamber leadless pacemaker will revolutionise care for our current patients and create a significant opportunity to expand the number of people we can serve, including children. 'By eliminating traditional wires (leads) and surgical pockets, this leadless system significantly reduces the risk of complications such as infections, lead dislodgement, or vessel occlusion,' he said at a press conference at IJN today. He noted that the long-term complication rate is typically between one and two per cent, comparable to, and in some cases lower than, that of conventional pacemakers. To date, 18 patients have received the new device, with the first implantation conducted on May 27. This milestone builds on IJN's decade-long experience with leadless pacemaker technology, during which nearly 900 patients have undergone procedures involving wireless pacemakers. IJN chief clinical officer, Datuk Dr Shaiful Azmi Yahya (centre), presenting the first leadless dual-chamber pacemaker implant in Southeast Asia after a press conference at IJN today. — Bernama pic Dr Azlan said the AVEIR™ DR system offers a range of potential benefits, including a shorter procedure time typically between 20 minutes to one hour, depending on the patient's heart condition. 'The system also provides real-time pacing analysis, enabling physicians to confirm accurate device placement during the procedure before the final implantation into the heart chamber,' he said. IJN chief executive officer Prof Datuk Seri Dr Mohamed Ezani Md Taib said the initial cost of the procedure is slightly higher due to the new technology. 'As with any new technology, the initial cost is slightly higher. However, in general, IJN's charges are significantly lower than those at most private hospitals,' he said. On whether other hospitals in Malaysia could adopt the procedure, Dr Mohamed Ezani said it's not just about offering a service, it's about having the right expertise and infrastructure. 'People need to understand that this is not just about business. It's about having the clinical expertise, advanced technology, and the right facilities, something IJN is proud to offer.' 'At IJN, innovation isn't just about introducing new technology, it's about creating real, meaningful impact. The AVEIR™ DR implantation marks a leap forward in cardiac care and reinforces our role as a regional leader,' he said. He also emphasised the importance of awareness and early intervention in addressing cardiovascular disease, which remains a significant health challenge in Malaysia. The AVEIR™ DR system, designed for patients with slow or irregular heart rhythms, marks a major breakthrough in cardiac pacing. Unlike traditional pacemakers, it consists of two miniaturised devices, each one-tenth the size of conventional models, implanted directly into the heart's right atrium and ventricle. As the world's first dual-chamber leadless pacemaker, it provides synchronised, beat-to-beat pacing without the risks associated with leads. The system features a minimally invasive design, long-term retrievability, and future-ready adaptability. In 2018, IJN made history as the first hospital outside the United States to implant the world's smallest pacemaker, the Micra AV. — Bernama KUALA LUMPUR, June 5 — The National Heart Institute (IJN) has made medical history by becoming the first centre in South-east Asia to successfully implant the world's first dual-chamber leadless pacemaker system, the Abbott AVEIR™ DR. Senior consultant cardiologist and Interventional Electrophysiology & Implantable Devices clinical director Datuk Dr Azlan Hussin said the achievement reflects IJN's commitment to setting new standards in cardiac care both in Malaysia and the region. 'This groundbreaking dual-chamber leadless pacemaker will revolutionise care for our current patients and create a significant opportunity to expand the number of people we can serve, including children. 'By eliminating traditional wires (leads) and surgical pockets, this leadless system significantly reduces the risk of complications such as infections, lead dislodgement, or vessel occlusion,' he said at a press conference at IJN today. He noted that the long-term complication rate is typically between one and two per cent, comparable to, and in some cases lower than, that of conventional pacemakers. To date, 18 patients have received the new device, with the first implantation conducted on May 27. This milestone builds on IJN's decade-long experience with leadless pacemaker technology, during which nearly 900 patients have undergone procedures involving wireless pacemakers. Dr Azlan said the AVEIR™ DR system offers a range of potential benefits, including a shorter procedure time typically between 20 minutes to one hour, depending on the patient's heart condition. 'The system also provides real-time pacing analysis, enabling physicians to confirm accurate device placement during the procedure before the final implantation into the heart chamber,' he said. IJN chief executive officer Prof Datuk Seri Dr Mohamed Ezani Md Taib said the initial cost of the procedure is slightly higher due to the new technology. 'As with any new technology, the initial cost is slightly higher. However, in general, IJN's charges are significantly lower than those at most private hospitals,' he said. On whether other hospitals in Malaysia could adopt the procedure, Dr Mohamed Ezani said it's not just about offering a service, it's about having the right expertise and infrastructure. 'People need to understand that this is not just about business. It's about having the clinical expertise, advanced technology, and the right facilities, something IJN is proud to offer.' 'At IJN, innovation isn't just about introducing new technology, it's about creating real, meaningful impact. The AVEIR™ DR implantation marks a leap forward in cardiac care and reinforces our role as a regional leader,' he said. He also emphasised the importance of awareness and early intervention in addressing cardiovascular disease, which remains a significant health challenge in Malaysia. The AVEIR™ DR system, designed for patients with slow or irregular heart rhythms, marks a major breakthrough in cardiac pacing. Unlike traditional pacemakers, it consists of two miniaturised devices, each one-tenth the size of conventional models, implanted directly into the heart's right atrium and ventricle. As the world's first dual-chamber leadless pacemaker, it provides synchronised, beat-to-beat pacing without the risks associated with leads. The system features a minimally invasive design, long-term retrievability, and future-ready adaptability. In 2018, IJN made history as the first hospital outside the United States to implant the world's smallest pacemaker, the Micra AV. — Bernama
Zawya
12-05-2025
- Health
- Zawya
Aman Hospital makes history as first private hospital in Qatar to perform TAVI heart intervention
Doha, Qatar – Aman Hospital has achieved a groundbreaking milestone in cardiac care by becoming the first private hospital in Qatar to successfully perform a Transcatheter Aortic Valve Implantation (TAVI), a minimally invasive life-saving procedure for patients with severe aortic stenosis. This landmark achievement underscores Aman Hospital's leadership in advanced cardiovascular treatments and its commitment to delivering world-class, innovative healthcare solutions to the community. The TAVI procedure, performed by Aman Hospital's expert cardiovascular team, led by Dr. Mohammed Al Hijji, Interventional Cardiologist at Aman Hospital (Weill Cornell Medicine-Qatar, 2011), offers a safer alternative to open-heart surgery for high-risk patients, ensuring faster recovery and improved outcomes. Dr. Hussain Ismaeel, Head of Cardiology at Aman Hospital, said " This delivers to our commitment to serving our patients with the best available. This procedure crowns others that Dr. Hijji has performed, and is a peak at what the Medical Services at Aman hospital offer across various specialties. It's indeed a moment of pride". This achievement follows a series of pioneering milestones in structural heart disease within the private sector, including transcatheter mitral valve repair and atrial septal defect closure procedures performed at Aman Hospital. Dr. Mohammed Al Hijji stated, 'This accomplishment reflects our dedication to pioneering cutting-edge cardiac interventions in Qatar. The successful TAVI procedure is a testament to our team's expertise and the hospital's advanced infrastructure, enabling us to provide exceptional care to patients with complex heart conditions'. Aman Hospital continues to set new benchmarks in healthcare excellence, combining state-of-the-art technology, highly skilled specialists, and patient-centered care. About Aman Hospital Aman Hospital is a private luxurious health facility at the forefront of elevating medical care in Qatar and the region, with a focus on a multidisciplinary team approach combining unparalleled professional expertise, cutting-edge technology, and service excellence. Aman hospital offers a wide range of medical services covering more than twenty specialties. Aman Hospital has developed five centers of excellence, Cardio metabolic Center of Excellence, Ophthalmology Center of Excellence, Pediatrics Center of Excellence, Pain Relief Center of Excellence, and Women Wellbeing Center of Excellence, which all exceptionally provide personalized treatment plans and expertise dedicated to excellence in patient care. Aman Hospital is the first hospital globally outside the UK to become a member of Imperial College Healthcare. Aman Hospital is also the first private hospital in Qatar to become a JCI-accredited healthcare institution and the first American Heart Association (AHA) Training Center, recognized for its commitment to quality, safety, and medical innovation. For media inquiries, please contact: Aman Hospital Press Department +974 4400 4400 info@ END
Yahoo
10-05-2025
- Health
- Yahoo
WVU-Medicine PCH announces new access to improved cardiac care
princeton — WVU Medicine Princeton Community Hospital announced its new affiliation Friday with the WVU Heart and Vascular Institute, a partnership that will provide improved access to expert cardiac care services for residents across the region. The WVU Heart and Vascular Institute is one of the nation's top-rated cardiac programs. A new board-certified cardiologist and electrophysiologist, Dr. Kiran Kanjerla, also was introduced to the community during Friday's ceremony. PCH President and CEO Karen Bowling told the crowd assembled at the new WVU Heart and Vascular Institute Cardiology Clinic, which is located on the third floor of PCH's North Tower, that the new signage outside marked the arrival of top-tier heart care. 'I tell everyone I'm so proud of the work we've done over the last four years,' Bowling said. 'This is just a monumental day. An accumulation of a lot of work we've been doing to ensure that our patients and our region continue to get the best, highest-quality care close to home, in partnership with the renowned Heart and Vascular Institute.' Bowling said PCH's new affiliation with the WVU Heart and Vascular Institute will bring improved access to expert cardiac care to the region. 'When you think of our geographic region, you know heart disease is very prevalent,' Bowling said of the Southern West Virginia, Southwest Virginia region that is served by WVU Medicine PCH. Dr. George Sokos, chair of the WVU Department off Cardiology, said everyone deserves access to the same level of cardiac care regardless of where they live. 'We think everybody deserves the same level of care, no matter where you are — and it's possible here, close to home, to receive the same care you'd get at Ruby or in Morgantown,' Sokos said. 'That's what we're striving to do.' Sokos said PCH's new affiliation with WVU Heart and Vascular Institute will provide improved access to cardiac care. 'It's really about trying to make it a place where someone can come and get all of the cardiac services they need,' Sokos said. 'This is an exciting time,' added PCH Interventional Cardiologist Dr. Stephen Ward, who introduced Kanjerla as the hospital's newest cardiac electrophysiologist. 'In the last few weeks, we've had Dr. Kenjerla start with us, and he brings great experience — fellowship-trained in electrophysiology at George Washington University, which is a huge plus for our area. He's already making an impact; his very first consult helped us avoid a patient transfer by enabling timely device placement right here at our hospital.' Kanjerla said he started working at PCH a couple of weeks ago, and will be assisting patients with permanent pacemakers and implantable cardiac defibrillator procedures. Starting May 19, Kanjerla will offer services in both general cardiology and electrophysiology, according to Cassandra Stalzer, director of public relations and marketing for WVU Medicine PCH. His practice will also include outpatient device checks and cardiac clearance evaluations. She said Kanjerla is now accepting referrals, and new patient appointments begin May 19 in Suite B of the PCH North Tower. Kanjerla said he will treat a wide range of heart conditions including atrial fibrillation, arrhythmias, heart failure, coronary artery disease, and hypertension. Contact Charles Owens at cowens@
